Johnson & JohnsonJNJ:NYQ

100.36
0.18 / 0.18%
1.26m
17.45%
0.5911
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Apr 23 2014 16:02 BST.

Summary

Johnson & Johnson (JNJ:NYQ) set a new 52-week high during Tuesday's trading session when it reached 100.75. Over this period, the share price is up 18.92%.

52-week range
Today
82.12
Jun 20 2013
100.75
Apr 22 2014
Markit short selling activity
Low
Medium
High
Open100.24
Day high100.49
Day low99.92
Bid100.36
Offer100.46
Previous close100.18
Average volume9.55m
Shares outstanding2.83bn
Free float2.83bn
P/E (TTM)19.15
Market cap283.34bn USD
EPS (TTM)5.23 USD
Annual div (TTM)2.64 USD
Annual div yield (TTM)2.64%
Div ex-dateFeb 21 2014
Div pay-dateMar 11 2014

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Johnson & Johnson+1.66%+4.65%+9.00%+17.48%+95.31%
S&P 500 INDEX+0.93%+0.70%+7.63%+19.05%+120.63%
USA/HEALTH CARE+2.21%-0.52%+9.23%+17.17%--
USA/PHARMACEUTICALS+3.30%+1.74%+11.68%+14.14%--
As of Apr 23 2014 15:48 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.